Edition:
India

AtriCure Inc (ATRC.OQ)

ATRC.OQ on NASDAQ Stock Exchange Global Market

27.75USD
22 Jun 2018
Change (% chg)

$-0.19 (-0.68%)
Prev Close
$27.94
Open
$27.94
Day's High
$27.94
Day's Low
$27.25
Volume
323,661
Avg. Vol
69,200
52-wk High
$30.90
52-wk Low
$14.89

Chart for

About

AtriCure, Inc. is an atrial fibrillation (Afib) solutions company. The Company develops, manufactures, and sells devices designed primarily for the surgical ablation of cardiac tissue and systems designed for the exclusion of the left atrial appendage. It has various product lines for the ablation of cardiac tissue, including... (more)

Overall

Beta: 0.75
Market Cap(Mil.): $804.79
Shares Outstanding(Mil.): 34.33
Dividend: --
Yield (%): --

Financials

BRIEF-Atricure Inc Q1 Loss Per Share $0.31

* Q1 EARNINGS PER SHARE VIEW $-0.27 -- THOMSON REUTERS I/B/E/S Source text for Eikon: Further company coverage:

27 Apr 2018

BRIEF-Atricure Posts Q4 Loss Per Share $0.08

* ATRICURE REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS

27 Feb 2018

BRIEF-Atricure Inc Launches Atriclip Flex V Device In U.S.

* ATRICURE INC - ‍LAUNCHES ATRICLIP FLEX•V DEVICE IN UNITED STATES​ Source text for Eikon: Further company coverage:

22 Feb 2018

BRIEF-Atricure Sees FY 2018 Revenue About $190 Million To $196 Million

* FY2017 REVENUE VIEW $173.9 MILLION -- THOMSON REUTERS I/B/E/S

08 Jan 2018

Competitors

  Price Chg
Johnson & Johnson (JNJ.N) $122.84 +1.39
St Jude Medical Inc (STJ.N) -- --

Earnings vs. Estimates